Mylan says Teva offer too low and stock 'unacceptable'
April 27, 2015 at 12:10 PM EDT
(Reuters) - Mylan NV rejected Teva Pharmaceutical Industries Ltd's unsolicited $40 billion takeover offer on Monday, saying it was too low and calling Teva stock an "unacceptable" currency.
